Skin genetically engineered as a bioreactor or a 'metabolic sink'

Cells Tissues Organs

Volumn 172, Issue 2, 2002, Pages 96-104

  Christensen, Rikke ^a   Jensen, Uffe Birk ^a   Jensen, Thomas G ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Metabolic diseases; Ornithine aminotransferase deficiency; Phenylketonuria; Stem cells

Indexed keywords

ADENOSINE DEAMINASE; ADENOVIRUS VECTOR; APOLIPOPROTEIN A1; BIOPTERIN; LOW DENSITY LIPOPROTEIN RECEPTOR; ORNITHINE OXOACID AMINOTRANSFERASE; PHENYLALANINE 4 MONOOXYGENASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ARTICLE; AUTOTRANSPLANTATION; BIOREACTOR; CLINICAL TRIAL; ENZYME DEFICIENCY; GENE EXPRESSION; GENE THERAPY; GENETIC ENGINEERING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPHENYLALANINEMIA; KERATINOCYTE; NONHUMAN; PHENYLKETONURIA; PRIORITY JOURNAL; PROMOTER REGION; RETINA GYRATE ATROPHY; CYTOLOGY; EPIDERMIS; GENE TRANSFER; GENETICS; METABOLIC CLEARANCE RATE; METABOLIC DISORDER; METABOLISM; METHODOLOGY; REVIEW; STEM CELL; TRANSPLANTATION;

BIOREACTORS; EPIDERMIS; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; HUMANS; KERATINOCYTES; METABOLIC CLEARANCE RATE; METABOLIC DISEASES; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036436771     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065612     Document Type: Article

References (42)

1. Barra, R.M., E.S. Fenjves, L.B. Taichman (1994) Secretion of apolipoprotein E by basal cells in cultures of epidermal keratinocytes. J Invest Dermatol 102: 61-66.
2. Christensen, R., S. Kolvraa, R.M. Blaese, T.G. Jensen (2000) Development of a skin based metabolic sink for phenylalanine by overexpression of phenylalanine hydroxylase and GTP cyclohydrolase in primary human keratinocytes. Gene Ther 7: 1971-1978.
3. Deng, H., K.A. Choate, Q. Lin, P.A. Khavari (1998) High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques 25: 274-280.
4. Deng, H., Q. Lin, P.A. Khavari (1997) Sustainable cutaneous gene delivery. Nat Biotechnol 15: 1388-1391.
5. Fakharzadeh, S.S., Y. Zhang, R. Sarkar, H.H. Kazazian, Jr. (2000) Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 95: 2799-2805.
6. Fang, B., R.C. Eisensmith, X.H. Li, M.J. Finegold, A. Shedlovsky, W. Dove, S.L. Woo (1994) Gene therapy for phenylketonuria: Phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther 1: 247-254.
7. Fenjves, E.S., P.M. Schwartz, R.M. Blaese, L.B. Taichman (1997) Keratinocyte gene therapy for adenosine deaminase deficiency: A model approach for inherited metabolic disorders. Hum Gene Ther 8: 911-917.
8. Fenjves, E.S., J. Smith, S. Zaradic, L.B. Taichman (1994) Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy. Hum Gene Ther 5: 1241-1248.
9. Garlick, J.A., A.B. Katz, E.S. Fenjves, L.B. Taichman (1991) Retrovirus-mediated transduction of cultured epidermal keratinocytes. J Invest Dermatol 97: 824-829.
10. Gerrard, A.J., D.L. Hudson, G.G. Brownlee, F.M. Watt (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3: 180-183.
11. Ghazizadeh, S., R. Harrington, L. Taichman (1999) In vivo transduction of mouse epidermis with recombinant retroviral vectors: Implications for cutaneous gene therapy. Gene Ther 6: 1267-1275.
12. Gould, R.G., R.P. Cook (1958) The Metabolism of Cholesterol and Other Sterols in the Animal Organism. I. Cholesterol. New York, Academic Press.
13. Harding, C.O., K. Wild, D. Chang, A. Messing, J.A. Wolff (1998) Metabolic engineering as therapy for inborn errors of metabolism - Development of mice with phenylalanine hydroxylase expression in muscle. Gene Ther 5: 677-683.
14. Hengge, U.R., A. Mirmohammadsadegh (2000) Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2: 188-194.
15. Jensen, T.G., D.M. Sullivan, R.A. Morgan, L.B. Taichman, R.B. Nussenblatt, R.M. Blaese, K.G. Csaky (1997) Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients. Hum Gene Ther 8: 2125-2132.
16. Jensen, U.B., T.G. Jensen, P.K. Jensen, J. Rygaard, B.S. Hansen, J. Fogh, S. Kolvraa, L. Bolund (1994) Gene transfer into cultured human epidermis and its transplantation onto immunodeficient mice: An experimental model for somatic gene therapy. J Invest Dermatol 103: 391-394.
17. Jones, P.H. (1996) Isolation and characterization of human epidermal stem cells. Clin Sci (Colch) 91: 141-146.
18. Jones, S.N., M. Grompe, M.I. Munir, G. Veres, W.J. Craigen, C.T. Caskey (1990) Ectopic correction of ornithine transcarbamylase deficiency in sparse fur mice. J Biol Chem 265: 14684-14690.
19. Kaiser-Kupfer, M.I., F.M. de Monasterio, D. Valle, M. Walser, S. Brusilow (1980) Gyrate atrophy of the choroid and retina: Improved visual function following reduction of plasma ornithine by diet. Science 210: 1128-1131.
20. Kolodka, T.M., J.A. Garlick, L.B. Taichman (1998) Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA 95: 4356-4361.
21. Kuwabara, T., Y. Ishikawa, M.I. Kaiser-Kupfer (1981) Experimental model of gyrate atrophy in animals. Ophthalmology 88: 331-335.
22. Ledley, F.D., H.E. Grenett, M. McGinnis-Shelnutt, S.L. Woo (1986) Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells. Proc Natl Acad Sci USA 83: 409-413.
23. Lenke, R.R., H.L. Levy (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303: 1202-1208.
24. Levy, L., S. Broad, A.J. Zhu, J.M. Carroll, I. Khazaal, B. Peault, F.M. Watt (1998) Optimised retroviral infection of human epidermal keratinocytes: Long-term expression of transduced integrin gene following grafting on to SCID mice. Gene Ther 5: 913-922.
25. Lin, C.M., Y. Tan, Y.M. Lee, C.C. Chang, K.J. Hsiao (1997) Expression of human phenylalanine hydroxylase activity in T lymphocytes of classical phenylketonuria children by retroviral-mediated gene transfer. J Inherit Metab Dis 20: 742-754.
26. Liu, T.J., M.A. Kay, G.J. Darlington, S.L. Woo (1992) Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient mice. Somat Cell Mol Genet 18: 89-96.
27. Mathor, M.B., G. Ferrari, E. Dellambra, M. Cilli, F. Mavilio, R. Cancedda, M. De Luca (1996) Clonal analysis of stably transduced human epidermal stem cells in culture. Proc Natl Acad Sci USA 93: 10371-10376.
28. Morgan, J.R., Y. Barrandon, H. Green, R.C. Mulligan (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237: 1476-1479.
29. Nagasaki, Y., Y. Matsubara, H. Takano, K. Fujii, M. Senoo, J. Akanuma, K. Takahashi, S. Kure, M. Hara, Y. Kanegae, I. Saito, K. Narisawa (1999) Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer. Pediatr Res 45: 465-473.
30. Pfutzner, W., U.R. Hengge, M.A. Joari, R.A. Foster, J.C. Vogel (1999) Selection of keratinocytes transduced with the multidrug resistance gene in an in vitro skin model presents a strategy for enhancing gene expression in vivo. Hum Gene Ther 10: 2811-2821.
31. Ponder, K.P., S. Gupta, F. Leland, G. Darlington, M. Finegold, J. DeMayo, F.D. Ledley, J.R. Chowdhury, S.L. Woo (1991) Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 88: 1217-1221.
32. Potten, C.S. (1981) Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int Rev Cytol 69: 271-318.
33. Scriver, C.R., S. Kaufman, R.C. Eisensmith, S.L.C. Woo (1995) The hyperphenylalaninemias; in The Metabolic and Molecular Bases of Inherited Disease. Maidenhead, McGraw-Hill, pp 1015-1075.
34. Soltesz, G., D. Harris, I.Z. Mackenzie, A. Aynsley-Green (1985) The metabolic and endocrine milieu of the human fetus and mother at 18-21 weeks of gestation. I. Plasma amino acid concentrations. Pediatr Res 19: 91-93.
35. Sullivan, D.M., T.G. Jensen, L.B. Taichman, K.G. Csaky (1997) Ornithine-delta-aminotransferase expression and ornithine metabolism in cultured epidermal keratinocytes: Toward metabolic sink therapy for gyrate atrophy. Gene Ther 4: 1036-1044.
36. Valle, D., O. Simell (1995) The hyperornithinemias; in The Metabolic and Molecular Bases of Inherited Disease. Maidenhead, McGraw-Hill, pp 1147-1185.
37. Wang, X., S. Zinkel, K. Polonsky, E. Fuchs (1997) Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapy. Proc Natl Acad Sci USA 94: 219-226.
38. Waters, P.J., M.A. Parniak, B.R. Akerman, C.R. Scriver (2000) Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype. Mol Genet Metab 69: 101-110.
39. Waters, P.J., M.A. Parniak, A.S. Hewson, C.R. Scriver (1998) Alterations in protein aggregation and degradation due to mild and severe missense mutations (A104D, R157N) in the human phenylalanine hydroxylase gene (PAH). Hum Mutat 12: 344-354.
40. Wei, M.Q., D.V. Lejnieks, N. Ramesh, S. Lau, J. Seppen, W.R. Osborne (1999) Sustained gene expression in transplanted skin fibroblasts in rats. Gene Ther 6: 840-844.
41. Weinstein, G.D., J.L. McCullough, P. Ross (1984) Cell proliferation in normal epidermis. J Invest Dermatol 82: 623-628.
42. White, S.J., S.M. Page, P. Margaritis, G.G. Brownlee (1998) Long-term expression of human clotting factor IX from retrovirally transduced primary human keratinocytes in vivo. Hum Gene Ther 9: 1187-1195.